Los Angeles, CA -- (SBWire) -- 05/06/2019 --Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

In the last several years, global market of alzheimer's disease drug change huge.

The classification of alzheimer's disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast quickly in past five years.

Alzheimer's disease drug are widely used for Early to Moderate, Moderate to Severe stage treatment. The most proportion of alzheimer's disease drug used to Moderate to Severe, and the market share in 2016 is 55.82%.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1085486/global-alzheimer-s-disease-drug-market

The global Alzheimer's Disease Drug market was 2870 million US$ in 2018 and is expected to 1280 million US$ by the end of 2025, growing at a CAGR of -11.0% between 2019 and 2025.

This report studies the Alzheimer's Disease Drug market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Alzheimer's Disease Drug in these regions, from 2014 to 2025, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Allergan

Eisai

Novartis

Daiichi Sankyo

Merz Pharma

Pfizer

Johnson & Johnson

Lundbeck

By the product type, the market is primarily split into

Donepezil

Memantine

Rivastigmine

By the end users/application, this report covers the following segments

Early to Moderate Stages

Moderate to Severe Stages

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

Rest of Middle East & Africa

The study objectives of this report are:

To study and analyze the global Alzheimer's Disease Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.

To understand the structure of Alzheimer's Disease Drug market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Alzheimer's Disease Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Alzheimer's Disease Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Alzheimer's Disease Drug submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Get Full Report Now at USD 3,550 @ https://www.qyresearch.com/settlement/pre/fa4d0b129df639595572af2e485d472a,0,1,Global%20Alzheimer's%20Disease%20Drug%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.